Department of Internal Medicine, University of New Mexico School of Medicine, MSC10 5550, 1 University of New Mexico, Albuquerque, NM, 87131, USA.
J Gen Intern Med. 2019 Jun;34(6):1053-1057. doi: 10.1007/s11606-019-04835-9. Epub 2019 Feb 19.
Anti-glutamic acid decarboxylase (anti-GAD) antibodies are linked with both autoimmune diabetes and the rare neurological disorder stiff person syndrome (SPS). SPS is an uncommon autoimmune-mediated condition characterized by painful episodic spasms and progressive muscle rigidity. We present the case of a 23-year-old non-diabetic, insulin-naïve woman with known SPS who was hospitalized for SPS-related symptomatology. The patient quickly developed type 1 diabetes mellitus (T1DM) with unexpectedly large insulin requirements. To our knowledge, there are no other reports describing rapid T1DM development during an acute hospitalization for SPS and fewer than 5 case reports describing the association of SPS with extreme insulin resistance. Our case highlights the key clinical features, pathology, and pathogenesis of both SPS and T1DM and explores the relationship between the two disease processes.
抗谷氨酸脱羧酶 (anti-GAD) 抗体与自身免疫性糖尿病和罕见的神经疾病僵人综合征 (SPS) 有关。SPS 是一种罕见的自身免疫介导的疾病,其特征是疼痛性阵发性痉挛和进行性肌肉僵硬。我们报告了一例 23 岁的非糖尿病、未使用胰岛素的 SPS 已知患者,因 SPS 相关症状住院治疗。该患者迅速发展为 1 型糖尿病 (T1DM),胰岛素需求量出乎意料地大。据我们所知,没有其他报告描述在急性 SPS 住院期间快速发生 T1DM,也少于 5 份报告描述 SPS 与极端胰岛素抵抗有关。我们的病例突出了 SPS 和 T1DM 的关键临床特征、病理学和发病机制,并探讨了这两种疾病过程之间的关系。